Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 8722857 Anti-CD79B antibodies and immunoconjugates and methods of use

Patent 8722857 was granted and assigned to Genentech on May, 2014 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Genentech
Genentech
0
Date Filed
January 14, 2009
0
Date of Patent
May 13, 2014
0
Patent Application Number
12353917
0
Patent Citations Received
‌
US Patent 12016842 Methods of using anti-CD79b immunoconjugates
0
‌
US Patent 11692041 Antibody molecules which bind CD45
0
‌
US Patent 11866496 Humanized anti-CD79B antibodies and immunoconjugates and methods of use
0
‌
US Patent 11938194 Cysteine mutated antibodies for conjugation
0
Patent Inventor Names
Andrew Polson
0
David Dornan
0
Jagath Reddy Junutula
0
Kristi Elkins
0
Mark Dennis
0
Yvonne Chen
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
8722857
0
Patent Primary Examiner
‌
Ron Schwadron
0

Find more entities like US Patent 8722857 Anti-CD79B antibodies and immunoconjugates and methods of use

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.